SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 11, 2004 (March 11,2004)
ENDO PHARMACEUTICALS HOLDINGS INC.
(Exact name of registrant as specified in its charter)| | | | | | | |
| DELAWARE | | 001-15989 | | | | 13-4022871 |
|
| (State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | | | | | | |
100 Painters Drive
Chadds Ford, Pennsylvania | | | | | 19317 | |
|
| (Address of principal executive offices) | | (Zip Code) |
(610) 558-9800
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits.
| (a) | | Financial Statements of Business Acquired. |
Not applicable.
| (b) | | Pro Forma Financial Information. |
Not applicable.
| | | |
Exhibit Number
| | Description
|
| 99.1 | | Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated March 11, 2004 |
Item 9. Regulation FD Disclosure.
On March 11, 2004, the Registrant intends to make a slide presentation at theSG Cowen, 24th Annual Health Care Conferencein Boston, Massachusetts, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | | | |
| | ENDO PHARMACEUTICALS HOLDINGS INC. | |
| | (Registrant)
| |
| | By: | /s/ CAROL A. AMMON | |
| | | Name: | Carol A. Ammon | |
| | | Title: | Chairman & Chief Executive Officer | |
| |
Dated: March 11, 2004
INDEX TO EXHIBITS
| | | |
Exhibit No.
| | Description
|
| 99.1 | | Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated March 11, 2004 |
